Open AccessBetatrophin association with serum triglyceride levels in obstructive sleep apnea patients
Author(s) -
Bünyamin Sertoğullarından,
Ahmet Ufuk Kömüroğlu,
Rıfkı Üçler,
Hülya Günbatar,
Aysel Sünnetçioğlu,
Erdem Çokluk
Publication year - 2019
Publication title -
annals of thoracic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.639
H-Index - 33
eISSN - 1817-1737
pISSN - 1998-3557
DOI - 10.4103/atm.atm_52_18
Subject(s) - medicine , adiponectin , dyslipidemia , obstructive sleep apnea , endocrinology , leptin , triglyceride , metabolic syndrome , sleep apnea , polysomnography , diabetes mellitus , obesity , insulin resistance , cholesterol , apnea
Obstructive sleep apnea (OSA) is a common sleep problem, in which patients are at increased risk for metabolic and cardiovascular problems, including metabolic syndrome, diabetes mellitus (DM), and dyslipidemia. Betatrophin is a novel protein that regulates fatty acid and triglyceride (TG) metabolism and is related to obesity and metabolic abnormalities, including metabolic syndrome, DM, and dyslipidemia. Although OSA and betatrophin share common abnormalities, their relationship has not been investigated.